These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37551838)

  • 41. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.
    Sun L; Wang L; Chen T; Yao B; Wang Y; Li Q; Yang W; Liu Z
    J Cell Mol Med; 2019 Dec; 23(12):8292-8304. PubMed ID: 31576658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Follicular Fluid-Derived Exosomal MicroRNA-18b-5p Regulates PTEN-Mediated PI3K/Akt/mTOR Signaling Pathway to Inhibit Polycystic Ovary Syndrome Development.
    Zhou Z; Tu Z; Zhang J; Tan C; Shen X; Wan B; Li Y; Wang A; Zhao L; Hu J; Ma N; Zhou J; Chen L; Song Y; Lu W
    Mol Neurobiol; 2022 Apr; 59(4):2520-2531. PubMed ID: 35092573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma.
    Barzegar Behrooz A; Talaie Z; Jusheghani F; Łos MJ; Klonisch T; Ghavami S
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.
    Li T; Zhou W; Li Y; Gan Y; Peng Y; Xiao Q; Ouyang C; Wu A; Zhang S; Liu J; Fan L; Han D; Wei Y; Shu G; Yin G
    PLoS One; 2019; 14(4):e0214822. PubMed ID: 30939162
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CircABCC3 knockdown inhibits glioblastoma cell malignancy by regulating miR-770-5p/SOX2 axis through PI3K/AKT signaling pathway.
    Zhang H; Xu W
    Brain Res; 2021 Aug; 1764():147465. PubMed ID: 33811842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR.
    Zhang S; Wang M; Li Q; Zhu P
    Cancer Biomark; 2017 Dec; 21(1):179-186. PubMed ID: 29081412
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
    Liu Y; Yang H
    Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AC016405.3, a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma.
    Ren S; Xu Y
    Cancer Sci; 2019 May; 110(5):1621-1632. PubMed ID: 30888082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-30c-5p loss-induced PELI1 accumulation regulates cell proliferation and migration via activating PI3K/AKT pathway in papillary thyroid carcinoma.
    Zheng T; Zhou Y; Xu X; Qi X; Liu J; Pu Y; Zhang S; Gao X; Luo X; Li M; Wang X; Dong L; Wang Y; Mao C
    J Transl Med; 2022 Jan; 20(1):20. PubMed ID: 34991623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CircHGS enhances the progression of bladder cancer by regulating the miR-513a-5p/VEGFC axis and activating the AKT/mTOR signaling pathway.
    Zhu Y; Zuo L; Xiong H; Li S; Chen R; Liu H
    Cell Cycle; 2023 Apr; 22(8):919-938. PubMed ID: 36617735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-425-5p promotes breast cancer cell growth by inducing PI3K/AKT signaling.
    Zhang LF; Zhang JG; Zhou H; Dai TT; Guo FB; Xu SY; Chen Y
    Kaohsiung J Med Sci; 2020 Apr; 36(4):250-256. PubMed ID: 31688991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-98-5p modulates cervical cancer progression via controlling PI3K/AKT pathway.
    Xiao R; Wang H; Yang B
    Bioengineered; 2021 Dec; 12(2):10596-10607. PubMed ID: 34895048
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carnosine inhibits glioblastoma growth independent from PI3K/Akt/mTOR signaling.
    Oppermann H; Faust H; Yamanishi U; Meixensberger J; Gaunitz F
    PLoS One; 2019; 14(6):e0218972. PubMed ID: 31247000
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of circADAMTS6-miR-324-5p-PIK3R3 ceRNA pathway may be a novel mechanism of IL-1β-induced osteoarthritic chondrocytes.
    Shen L; Ji C; Lin J; Yang H
    J Bone Miner Metab; 2022 May; 40(3):389-401. PubMed ID: 35333985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/Akt/mTOR signaling pathway.
    Zhang X; Shi H; Tang H; Fang Z; Wang J; Cui S
    Int J Mol Med; 2015 May; 35(5):1301-8. PubMed ID: 25760926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioinformatics identification of miR-514b-5p promotes NSCLC progression and induces PI3K/AKT and p38 pathways by targeting small glutamine-rich tetratricopeptide repeat-containing protein beta.
    Shi L; Kan J; Zhuo L; Wang S; Chen S; Zhang B; Ke B
    FEBS J; 2023 Feb; 290(4):1134-1150. PubMed ID: 36180981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway.
    Cheng Y; Xie P
    J Biochem Mol Toxicol; 2019 Nov; 33(11):e22392. PubMed ID: 31503386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma.
    De Bacco F; Orzan F; Erriquez J; Casanova E; Barault L; Albano R; D'Ambrosio A; Bigatto V; Reato G; Patanè M; Pollo B; Kuesters G; Dell'Aglio C; Casorzo L; Pellegatta S; Finocchiaro G; Comoglio PM; Boccaccio C
    Cell Rep; 2021 Jul; 36(4):109455. PubMed ID: 34320350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.